NCT00993889

Brief Summary

We would like to determine whether Virtual Reality (VR) analgesia continues to be effective for reducing pain when administered for a clinically relevant treatment duration over multiple, repeated exposures (i.e., up to ten sessions of physical therapy per patient).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 13, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 14, 2009

Completed
7.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

March 13, 2019

Status Verified

March 1, 2019

Enrollment Period

7.9 years

First QC Date

October 13, 2009

Last Update Submit

March 11, 2019

Conditions

Keywords

Virtual Reality Peds

Outcome Measures

Primary Outcomes (1)

  • Pain and anxiety

    pre and post procedure

Study Arms (3)

VR during Physical Therapy

EXPERIMENTAL

The subject will receive virtual reality during painful physical therapy sessions.

Behavioral: VR during Physical Therapy

VR background pain

EXPERIMENTAL

The subjects receives virtual reality, not during a physical therapy procedure, another time of the day for background pain.

Behavioral: VR Background Pain

No VR

EXPERIMENTAL

The subject will receive the usual standard treatment. At the end of the study, before being discharged from the hospital, the subject can experience the VR, not during a procedure.

Behavioral: NO VR

Interventions

Virtual Reality will be performed during a painful physical therapy procedure.

VR during Physical Therapy

Virtual Reality is used at anytime during the day for the background pain, not during physical therapy.

VR background pain
NO VRBEHAVIORAL

The subject will receive the usual standard treatment. At the end of the study, before being discharged from the hospital, the subject can experience the VR, not during a procedure.

No VR

Eligibility Criteria

Age5 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age greater than or equal to 8 years up to 20 yrs old
  • Compliant and able to complete subject evaluation
  • A minimum of 3 days of physical therapy, one physical therapy session per day
  • No history of psychiatric (DSM-IV-R Axis I) or developmental disorder that would interfere with decisional capacity
  • Not demonstrating delirium, psychosis, or any form of Organic Brain Disorder that would interfere with decisional capacity
  • Able to communicate verbally
  • Able to take oral medications
  • English-speaking

You may not qualify if:

  • \- Age less than 8 years, or greater than 20 years.
  • Not capable of indicating pain intensity
  • Not capable of filling out study measures
  • Hospitalization of fewer than 3 days
  • Evidence of traumatic brain injury
  • History of psychiatric (DSM-IV-R Axis I) disorder as evidenced in the admitting RN and MD admission notes, if interfering with decisional capacity
  • Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems that would interfere with decisional capacity
  • Unable to communicate verbally
  • Unable to take oral medications
  • History of sig. cardiac, endocrine, neurologic, metabolic, respiratory, gastrointestinal or genitourinary impairment that would interfere with treatment or decisional capacity
  • Receiving prophylaxis for alcohol or drug withdrawal
  • Developmental disability that would interfere with decisional capacity
  • Face/head/neck injuries preventing helmet use
  • Non-English-speaking
  • Extreme susceptibility to motion sickness
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Harborview Medical Center

Seattle, Washington, 98104-2499, United States

Location

MeSH Terms

Conditions

Burns

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • David R Patterson, Ph.D.

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD.ABPP. Professor

Study Record Dates

First Submitted

October 13, 2009

First Posted

October 14, 2009

Study Start

May 1, 2009

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

March 13, 2019

Record last verified: 2019-03

Locations